Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
株式のランク
#4184
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
株価
$2.29
時価総額
$3.83B
変化（1日）
3.06%
変化（1年）
-6.38%
国
CN
取引 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
カテゴリー
Healthcare
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（002603）の利益
Jun 2026 時点の利益 TTM: $246.26M
Shijiazhuang Yiling Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は $246.26M です。2023 年には $237.93M の利益を上げ、これは 2022 年の利益 $403.11M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Shijiazhuang Yiling Pharmaceutical Co., Ltd. の利益の推移（2008 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -89.29% |
US
|
|
| - | - |
IT
|
